Hook and thesis
First Solar is at an inflection point where macro policy and company-level booking trends are pushing in different directions. The post-election bump for renewables after the Democratic win has improved the policy backdrop for U.S. manufacturers; at the same time First Solar recently trimmed 2026 guidance and said it will be selective on new bookings. That combination creates a tactical opportunity: policy-driven sentiment can lift the shares while weaker demand keeps upside capped unless booking momentum returns.
My trade idea is a disciplined long: enter at $174.25, protect capital with a stop at $158.00, and target $220.00 over a mid-term window. This trade leans on near-term policy clarity and a heavy domestic backlog while respecting guidance cuts and execution risk.
What First Solar does and why the market should care
First Solar manufactures cadmium telluride (CdTe) solar modules and has leaned into higher-margin, project-specific contracts. The company remains a U.S.-centric manufacturing winner if trade protections favor domestic producers - a political tailwind that matters because tariffs and import restrictions can materially alter pricing, gross margins and the competitive landscape.
Practically, the market cares because First Solar marries industrial-scale manufacturing with an attractive backlog and a capital allocation policy that includes buybacks. Management reports a 44 GW backlog through 2030 and is exercising selectivity on new contracts to protect pricing - a sign they are prioritizing margins over market share.
Recent results and the booking puzzle
On 10/30/2026 First Solar reported Q3 results that were mixed. Q3 EPS came in at $5.30 (beat), with gross profit up 16.8%, but revenue declined 23% year-over-year to $1.23B. Management cut full-year 2026 sales guidance to $4.6B-$4.9B and lowered module shipment forecasts to 16-17 GW, citing slower customer procurement and weaker demand. That combination - EPS beat but falling sales and reduced guidance - is why the stock has pulled back.
Management also approved a $500M buyback while maintaining a net cash target of $1.5B-$2.0B and rolling out CuRe technology into India in early 2027. These moves are constructive for longer-term shareholder value but do not erase the short-term uncertainty around bookings.
Valuation framing
First Solar trades near $174.25 today with a snapshot market cap of roughly $18.7B. Key multiples and balance-sheet metrics from recent reporting include a P/E of about 10.3, price-to-book near 1.76, EV/EBITDA ~7.15, and free cash flow of about $233M. Debt is minimal - debt-to-equity is around 0.01 - giving the company flexibility.
Those multiples imply the market is assigning modest upside for growth and pricing power. Historically, First Solar has traded at higher multiples when volume growth and bookings were clear. For a cyclical manufacturing name with project execution risk, a single-digit EV/EBITDA and low P/E reflect the market’s skepticism; the trade aims to buy that skepticism cheaply while policy clarity reduces downside risk.
Technical and sentiment context
Technically the stock sits below key moving averages (10-, 20-, 50-day SMAs are all above current levels) and the 52-week high is $320.95 while the 52-week low is $165.86. Momentum indicators show some recovery - MACD is in bullish momentum even as RSI is neutral around 43 - which supports a tactical entry near current levels rather than buying a breakout.
Catalysts - what could drive the trade
- Policy clarity: Democratic control and clearer enforcement of Section 232 tariffs that favor domestic module manufacturers would strengthen First Solar’s pricing power and tender prospects.
- Booking acceleration: Improved procurement activity from U.S. developers or corporate buyers that leads to visible reacceleration in contracted bookings would validate the valuation gap and push multiples higher.
- Operational execution: Smooth CuRe rollout in India in early 2027 and steady gross margin improvement would convert backlog into profitable revenue growth.
- Capital returns: Effective deployment of the $500M buyback to reduce share count or opportunistic M&A could lift EPS and investor sentiment.
- Rate or financing relief: Any reduction in project financing costs would improve project economics and demand for domestic modules.
Trade plan - actionable details
Trade direction: Long
Entry price: $174.25
Stop loss: $158.00
Target price: $220.00
Horizon: mid term (45 trading days)
Rationale for the parameters: The entry sits near current levels to capture any policy-driven relief rally without chasing strength. The stop at $158 sits below the recent 52-week low area and gives the trade room for noise while cutting losses decisively if bookings or policy signals reverse. The $220 target is a measured move that assumes modest re-rating as clarity around Section 232 and selective booking momentum materialize; this represents roughly a 26% upside from entry within a 45-trading-day window, which is a realistic mid-term objective if catalysts align.
Risks and counterarguments
- Demand deterioration - The company cut 2026 guidance to $4.6B-$4.9B and shipment guidance to 16-17 GW. If customer procurement remains weak, revenue and margin pressure could persist and push the stock materially lower.
- Policy uncertainty despite political wins - A Democratic win increases the probability of supportive policy but does not guarantee immediate, material changes in procurement timelines or regulatory details. Section 232 clarity could be slower to translate into contracts than the market expects.
- Execution risk on technology ramp - The CuRe rollout and any next-gen initiatives carry execution and cost risks. Delays or subpar yields could pressure margins.
- Macroeconomic and financing headwinds - Elevated interest rates and higher project financing costs reduce project economics and could delay customer purchasing decisions.
- Backlog realism - A large backlog (44 GW) can be attractive, but it is only as valuable as the contracts it represents. Some backlog may be contingent or subject to renegotiation under weaker demand.
- Shareholder returns vs. capital needs - While management has authorized a $500M buyback and is targeting net cash, ongoing investments or plant changes (including potential plant closures) could alter capital allocation and cash flow.
Counterargument to the trade thesis
One could reasonably argue to stay on the sidelines or even take a short position: guidance was cut and module volume outlook trimmed, which directly weakens revenue visibility. If the market re-prices renewables on the basis of near-term demand rather than long-run policy, a rally tied to political headlines could prove fleeting. That said, this trade is structured to be catalyst-sensitive and capital-preserving: a hard stop at $158 limits payout to fundamentals if the booking picture deteriorates further.
What would change my mind
I would become more constructive and raise targets if we see a clear pickup in bookings - specifically, multi-gigawatt new contract announcements or a visible acceleration in firm customer procurement that pushes the company to re-open its volume guidance. I would turn cautious if bookings continue to stagnate, if management abandons its net cash target, or if Section 232 enforcement is softened materially, which would expose First Solar to low-cost competition and margin compression.
Conclusion
First Solar sits at an attractive risk-reward for a disciplined, mid-term tactical trade. The company has favorable structural catalysts - policy tailwinds and domestic manufacturing advantages - yet near-term demand and guidance cuts justify skepticism. The long at $174.25 with a stop at $158.00 and a target of $220.00 balances those forces: it buys policy-driven upside while protecting capital against continued booking weakness. Watch bookings and any explicit Section 232 guidance closely; those are the items that will decide whether this trade becomes a winner or a stop-out.